Rapid Dose Therapeutics 

Rapid Dose Therapeutics Corp., a life sciences enterprise based in Burlington, Canada, specializes in cutting-edge drug delivery systems aimed at enhancing health and well-being for individuals across Canada. Their core offering is the QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter remedies—directly into the bloodstream. The product line includes targeted solutions like QuickStrip energy, infused with caffeine; QuickStrip B12, providing vitamin B12; and QuickStrip sleep, which delivers melatonin. Furthermore, the company provides bespoke services encompassing product innovation, manufacturing, and strategic consultation to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing sectors. Rapid Dose Therapeutics also maintains a significant research partnership with McMaster University, jointly developing advanced biopolymer compositions for optimized thin-film drug delivery and pioneering an orally administered COVID-19 vaccine candidate.